These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5714381)

  • 1. [Clinical studies on the mechanism of action of 2-(2,6-dichlorphenylamino)-2-imidazolinehydrochloric acid (Catapresan)].
    Scheja HW; Strum A
    Verh Dtsch Ges Inn Med; 1968; 74():559-62. PubMed ID: 5714381
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 3. [Catapresan (2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride)--a new intraocular pressure lowering agent].
    Hasslinger C
    Klin Monbl Augenheilkd; 1969 Jan; 154(1):95-105. PubMed ID: 5364293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with the new antihypertensive agent Catapresan].
    Messerich J
    Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with Catapresan in the therapy of hypertension].
    Michel D
    Dtsch Med Wochenschr; 1968 Jul; 93(28):1375. PubMed ID: 5657231
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies on the antihypertensive effect of Catapresan].
    Kreuziger H; Brehm H
    Med Welt; 1968 Apr; 14():905-7. PubMed ID: 5718198
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catapresan--a new hypotensive agent].
    Tarkowska A
    Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the anti-hypertensive effectiveness of Catapresan (ST-155)].
    Ambrosioni E; Corbara F; Perri G
    G Clin Med; 1971 Mar; 52(3):247-65. PubMed ID: 5121120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our first experiences with the new hypotensive drug Catapresan].
    Grujić M; Robović Z; Perinović M; Rizvanbegović B; Sarić V; Vasiljević M
    Med Arh; 1968; 22(3):75-80. PubMed ID: 5191771
    [No Abstract]   [Full Text] [Related]  

  • 11. [Moxonidine. A new antihypertensive agent of central action].
    Leães CG; Rosito GA
    Arq Bras Cardiol; 1998 Jun; 70(6):443-8. PubMed ID: 9713089
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new hypotensive agent with central action].
    Fritel D
    Therapeutique; 1970 Nov; 46(9):893-5. PubMed ID: 5486137
    [No Abstract]   [Full Text] [Related]  

  • 13. Losartan--a new antihypertensive.
    Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of arterial hypertension with ST-155].
    Fonnesu C; Solinas F
    Clin Ter; 1970 Sep; 54(5):455-9. PubMed ID: 4949933
    [No Abstract]   [Full Text] [Related]  

  • 15. [A major hypotensive drug with central action: catapressan].
    Spach MO; Imbs JL; Bloch R; Schwartz J
    Presse Med (1893); 1971 Jan; 79(3):101. PubMed ID: 5539690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antihypertensive drug. Dual action lowers blood pressure more effectively].
    MMW Fortschr Med; 2001 May; 143(18):49. PubMed ID: 11387709
    [No Abstract]   [Full Text] [Related]  

  • 18. [ECG studies following oral administration of a new antihypertensive substance (Catapresan)].
    Strössenreuther H
    Med Monatsschr; 1966 Dec; 20(12):565-6. PubMed ID: 5980274
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
    Ferreira EB; Eichemberg R; Berlitz MF
    Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.